Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effect of Front-of-Package Labels on Intent to Purchase Packaged Foods in the Philippines

16 novembre 2026 aggiornato da: Johns Hopkins Bloomberg School of Public Health

Effect of Front-of-Package Labels on the Intent to Purchase Packaged Foods in the Philippines: A Five-Arm Randomized Controlled Trial

The Philippines is considering a mandatory front-of-package label (FoPL) for packaged foods. This randomized controlled trial will test which label design best helps consumers avoid products high in sugar, sodium, or saturated fat. Adults who buy packaged foods will be approached outside supermarkets and other food retailers in three locations: the City of Manila, Iloilo City, and the Municipality of San Jose, Dinagat Islands. After consent, each participant will be randomly assigned to one of five groups and will view mock packaged food products on a tablet: no label (control), a Nutrient Warning Label, a Multiple Traffic Light label, a Health Star Rating, or a Nutri-Grade style label. The main outcome is how likely participants say the participant is to buy products that contain nutrients of concern in excess. The study will also measure whether participants can correctly identify which nutrients are in excess, which of two similar products the participant would buy, and which product the participant thinks is healthier. Results will inform FoPL policy in the Philippines.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This is a five-arm, parallel-group, individually randomized trial with a single study visit of about 25 minutes. Trained research assistants recruit participants using street-intercept methods outside food retailers, screen for eligibility, and obtain written informed consent. Participants are randomized 1:1:1:1:1 in REDCap, stratified by study site, using an allocation table generated by an independent statistician; the enumerator does not know the allocation sequence in advance.

Within the assigned arm, participants complete: (1) single-product tasks, in which the participant views one mock product at a time (product order randomized), rate the intent to purchase on a 7-point scale, and indicate whether the product contains sugar, sodium, saturated fat, or protein in excess (protein is a distractor and is never in excess); (2) paired-product comparison tasks, in which, for three pairs of similar products showing different versions of the same label system, the participant's choose which product the participant would buy, which is healthier, and which the participant would be more worried about a child consuming; and (3) label acceptability questions, a label comparison task, and demographic questions. The Pan American Health Organization (PAHO) Nutrient Profile Model is used as an independent standard to classify products as containing sugar, sodium, or saturated fat in excess.

Sample size: 2,105 participants (approximately 701 per site; 421 per arm). This provides 80% power to detect a 0.36-point difference in mean intent to purchase (SD 1.5) for each label versus no label (Bonferroni alpha = 0.0125) and for pairwise comparisons among effective labels (alpha = 0.0083).

Primary analysis: a linear model of each participant's mean purchase-intent score across four products, with treatment arm as a fixed effect and no label as the reference category (four primary contrasts), adjusting for pre-specified baseline covariates that are imbalanced across arms. Multiplicity is controlled using the Hochberg step-down procedure. If any label is effective compared with no label, effective labels are compared pairwise (up to six contrasts). Statisticians are blinded to arm assignment for the primary outcome analysis.

Tipo di studio

Interventistico

Iscrizione (Stimato)

2105

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Dinagat Islands
      • San Jose, Dinagat Islands, Filippine
        • Non ancora reclutamento
        • Municipality of San Jose, Dinagat Islands
    • Iloilo
      • Iloilo City, Iloilo, Filippine
        • Non ancora reclutamento
        • Iloilo City
    • National Capital Region
      • Manila, National Capital Region, Filippine
        • Reclutamento
        • City of Manila

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 59 anni (Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Age 18 to 59 years
  • Purchases packaged foods
  • Resident of the Philippines
  • Able and willing to provide written informed consent

Exclusion Criteria:

  • Age under 18 or over 59 years
  • Does not purchase packaged foods
  • Not a resident of the Philippines
  • Adults lacking capacity to consent

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: No label (control)

Participants view mock packaged food products without any front-of-package label.

Sperimentale: Nutrient Warning Label (NWL)

Mock packaged food products display black octagonal warning labels for each nutrient (sugar, sodium, saturated fat) present in excess.

Front-of-package warning symbols flagging each nutrient of concern (sugar, sodium, saturated fat) that exceeds the label's nutrient profile threshold, applied to mock packaged food images shown on a tablet during a single study visit.

Altri nomi:
  • NWL
Sperimentale: Multiple Traffic Light (MTL)

Mock packaged food products display a Multiple Traffic Light label with red, amber, or green color coding of sugar, sodium, and saturated fat levels.

Front-of-package label showing levels of sugar, sodium, and saturated fat color-coded red, amber, or green, applied to mock packaged food images shown on a tablet during a single study visit.

Altri nomi:
  • MTL
Sperimentale: Health Star Rating (HSR)

Mock packaged food products display a Health Star Rating summary score (0.5 to 5 stars).

Front-of-package summary rating from 0.5 to 5 stars based on an underlying nutrient profile algorithm, applied to mock packaged food images shown on a tablet during a single study visit.

Altri nomi:
  • HSR
Sperimentale: Nutri-Grade style (NG)

Mock packaged food products display a Nutri-Grade style letter-grade label.

Front-of-package letter-grade summary label (Nutri-Grade style), applied to mock packaged food images shown on a tablet during a single study visit.

Altri nomi:
  • NG

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Mean Self-Reported Intent to Purchase Products Containing Nutrients of Concern in Excess
Lasso di tempo: During the single study visit (Day 1, approximately 25 minutes)

After viewing each of four mock packaged products containing sugar, sodium, and/or saturated fat in excess (per the PAHO Nutrient Profile Model), participants answer: "Imagine you were looking to buy [product]. Would you buy this product for yourself or your family?" on a fully labeled 7-point scale (1 = I would certainly not buy this product; 4 = Neutral; 7 = I would definitely buy this product). The outcome is the participant's mean score across the four products (range 1-7; higher scores indicate greater intent to purchase). Each front-of-package label arm is compared with the no-label control.

During the single study visit (Day 1, approximately 25 minutes)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Accuracy in Identifying Nutrients of Concern Present in Excess
Lasso di tempo: During the single study visit (Day 1)

For each single-product task, participants report whether the product contains sugar, sodium, saturated fat, and protein in excess (Yes / No / I don't know). Reported as the proportion of correct identifications (sensitivity and overall accuracy) per nutrient and pooled across products, compared between each label arm and no label and among effective labels. "I don't know" is counted as incorrect. Protein is never in excess; the false-positive rate for protein is also reported.

During the single study visit (Day 1)
Selection of the Healthier Product for Purchase in Paired Product Comparisons
Lasso di tempo: During the single study visit (Day 1)

For each of three pairs of similar products showing different versions of the assigned label system (e.g., fewer vs. more warnings), participants choose which product the participant would buy (Product A / Product B / Either / Neither). Outcome: selection of the healthier product (1) vs. any other response (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

During the single study visit (Day 1)
Correct Identification of the Healthier Product in Paired Product Comparisons
Lasso di tempo: During the single study visit (Day 1)

For each of three product pairs, participants choose which product is healthier (Product A / Product B / I don't know). Outcome: correct choice (1) vs. incorrect choice or "I don't know" (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

During the single study visit (Day 1)
Concern About Child Consumption in Paired Product Comparisons (proportion of participants selecting the less healthful product)
Lasso di tempo: During the single study visit (Day 1)

For each of three product pairs, participants choose which product the participant would be more worried about letting a child consume (Product A / Product B / I don't know). Reported as the proportion selecting the less healthful product, by arm.

During the single study visit (Day 1)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Megan E Henry, PhD, Johns Hopkins Bloomberg School of Public Health
  • Investigatore principale: TJ Robinson Moncatar, RN, MPH, PhD, University of the Philippines Manila, College of Public Health

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 novembre 2026

Completamento primario (Stimato)

1 dicembre 2026

Completamento dello studio (Stimato)

1 giugno 2027

Date di iscrizione allo studio

Primo inviato

16 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

16 novembre 2026

Primo Inserito (Effettivo)

20 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

20 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • IRB00033681
  • 90104337 (Altro numero di sovvenzione/finanziamento: Resolve to Save Lives)
  • UPMREB 2026-0392-01 (Altro identificatore: University of the Philippines Manila Research Ethics Board)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Under the Institutional Review Board (IRB) approved data management plan, individual participant data will not be shared with investigators outside the study team.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .